High variability in oral glucose tolerance among 1,128 patients with cystic fibrosis: a multicenter screening study.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4231037)

Published in PLoS One on November 13, 2014

Authors

Nicole Scheuing1, Reinhard W Holl1, Gerd Dockter2, Julia M Hermann1, Sibylle Junge3, Cordula Koerner-Rettberg4, Lutz Naehrlich5, Christina Smaczny6, Doris Staab7, Gabriela Thalhammer8, Silke van Koningsbruggen-Rietschel9, Manfred Ballmann4

Author Affiliations

1: Institute of Epidemiology and Medical Biometry, Central Institute for Biomedical Technology, University of Ulm, Ulm, Germany.
2: Cystic Fibrosis Centre, Saarland University Hospital for Pediatric and Adolescent Medicine, Homburg/Saar, Germany.
3: Clinic for Pediatric Pneumology and Neonatology, Hannover Medical School, Hannover, Germany.
4: Department of Pediatric Pulmonology, St. Josef Hospital Pediatric Clinic, Ruhr University Bochum, Bochum, Germany.
5: Department of Pediatrics, Justus-Liebig University Giessen, Giessen, Germany.
6: Medical Clinic I, Pneumology and Allergology, University Hospital Frankfurt/Main, Goethe University, Frankfurt/Main, Germany.
7: Division of Pulmonology and Immunology, Department of Pediatrics, Charité Berlin, Berlin, Germany.
8: Department for Pediatric Pulmonology and Allergology, Medical University of Graz, Graz, Austria.
9: Cystic Fibrosis Centre Cologne, Childrens Hospital, University of Cologne, Cologne, Germany.

Associated clinical trials:

Early Diagnosis of Diabetes Mellitus in Patients With Cystic Fibrosis | NCT00662714

Articles cited by this

Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care (2007) 6.24

Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med (2007) 4.43

Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia (1996) 2.53

Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care (2010) 2.52

Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care (2009) 2.50

Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr (1994) 1.34

Oral glucose tolerance testing in children with cystic fibrosis. Pediatr Diabetes (2010) 1.12

Body mass index percentiles for children and adolescents in Germany based on a nationally representative sample (KiGGS 2003-2006). Eur J Clin Nutr (2010) 1.11

Intra- and interindividual variability of glucose tolerance in an elderly population. J Clin Epidemiol (1991) 0.99

Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test. J Cyst Fibros (2013) 0.89

Natural history of glucose intolerance in patients with cystic fibrosis: ten-year prospective observation program. J Pediatr (2009) 0.85

Comparison of cystic fibrosis-related diabetes with type 1 diabetes based on a German/Austrian Pediatric Diabetes Registry. Diabetes Care (2012) 0.84

Why is insulin pump treatment rarely used in adolescents and young adults with cystic fibrosis-related diabetes? Pediatr Diabetes (2014) 0.80

Adherence to clinical care guidelines for cystic fibrosis-related diabetes in 659 German/Austrian patients. J Cyst Fibros (2014) 0.80

Diabetes in cystic fibrosis: multicenter screening results based on current guidelines. PLoS One (2013) 0.79